We are here to assist you.
Health Advisor
+91-8877772277Available 7 days a week
10:00 AM – 6:00 PM to support you with urgent concerns and guide you toward the right care.
Explore the claims, scientific evidence, and potential risks surrounding Rick Simpson Oil (RSO) as a cancer treatment. Understand the difference between RSO and other cannabis oils and what experts say.

Rick Simpson Oil (RSO) has gained significant attention, particularly within alternative health circles, for its purported ability to treat cancer. Developed by Canadian medical marijuana activist Rick Simpson, RSO is a potent form of cannabis oil rich in tetrahydrocannabinol (THC), the primary psychoactive compound in marijuana. Simpson himself claims to have successfully treated his skin cancer by applying RSO to the affected areas, which he states healed within days. This personal experience, coupled with early research findings, has fueled widespread interest and belief in RSO as a cancer cure.
Rick Simpson's journey with cannabis oil began after his diagnosis with skin cancer in 2003. Inspired by a 1975 study that suggested cannabinoids could slow the growth of lung cancer in mice, Simpson decided to experiment with cannabis oil. He reported remarkable success in treating his own condition, which led him to advocate for the use of RSO as a natural cancer remedy. According to Simpson's website, RSO is derived from Cannabis indica strains, known for their sedative effects, which he believes aid the body's healing processes.
While cancer treatment is the most prominent claim associated with RSO, proponents suggest it can also help manage a range of other health conditions. These include:
It is important to note that these are largely anecdotal claims, and robust scientific evidence to support these uses is often limited.
The scientific community's view on RSO as a cancer treatment is complex and evolving. While some research shows promise, other studies present conflicting results or highlight potential risks.
A significant body of research has focused on the effects of cannabinoids, including THC, on cancer cells in laboratory settings (cell cultures) and animal models. These studies have indicated that cannabinoids may possess properties that could potentially:
The 1975 study that inspired Rick Simpson is an example of such early research, showing that THC and another cannabinoid, cannabinol (CBN), slowed lung cancer growth in mice. More recent studies continue to explore these mechanisms, providing a basis for the ongoing interest in cannabis-based therapies for cancer.
However, the scientific landscape is not entirely in favor of RSO for cancer. Some research has yielded contradictory results. For instance, one study involving human cancer cells found that THC might actually accelerate the growth of certain types of lung and brain cancer cells. This highlights the complexity of how cannabinoids interact with different cancer types and individual biological systems.
Furthermore, much of the existing research has been conducted in vitro (in lab dishes) or in animal models. While these studies are crucial for understanding potential mechanisms, they do not always translate directly to effectiveness in humans.
In recent years, a few early-stage clinical trials have begun to investigate the effects of cannabinoids in human cancer patients. These trials have primarily focused on assessing the safety and tolerability of cannabinoids. While they have generally shown that cannabinoids can be safely administered to cancer patients, they have not yet provided definitive proof that cannabinoids can effectively treat or control cancer. Larger, long-term studies with human participants are essential to establish efficacy and optimal dosages.
As RSO contains high levels of THC, it is a psychoactive substance and can lead to a range of side effects. It is crucial for individuals considering RSO to be aware of these potential risks:
These effects are related to THC's impact on the brain and can include:
RSO can also cause physical reactions, such as:
It is important to note that these side effects are often temporary, typically lasting for a few hours after consumption. However, they can still pose risks, particularly concerning activities requiring alertness, such as driving or operating machinery.
RSO is distinct from other forms of cannabis oil due to its specific production method and high THC concentration. While other medicinal cannabis oils might focus on CBD (cannabidiol), which is non-psychoactive, RSO is characterized by its potent THC content. This difference is significant because THC and CBD have different effects on the body and have been studied for different therapeutic applications. RSO is typically made from indica strains, aiming for a full-spectrum extract that includes various cannabinoids and terpenes, believed by proponents to enhance its therapeutic effects through the
This section adds practical context and preventive advice to help readers make informed healthcare decisions. It is important to verify symptoms early, consult qualified doctors, and avoid self-medication for persistent health issues.
Maintaining healthy routines, following prescribed treatment plans, and attending regular checkups can improve outcomes. If symptoms worsen or red-flag signs appear, immediate medical evaluation is recommended.
Track symptoms and duration.
Follow diagnosis and treatment from a licensed practitioner.
Review medication side effects with your doctor.
Seek urgent care for severe warning signs.

Discover 3 subtle signs of mouth cancer often dismissed as minor issues. Learn why early detection is crucial for effective treatment.
April 23, 2026
Learn about potential side effects of CML treatments like TKIs, interferon, chemotherapy, and stem cell transplants. Understand what to expect and how to communicate with your doctor for effective management.
April 1, 2026

Discover essential support resources, financial aid options, and community connections for individuals navigating life with Chronic Myeloid Leukemia (CML). Find practical advice and empathetic guidance.
April 1, 2026